
Episode 81. Current COVID Risk Assessment: BA.2.86 Variant, Boosters, and More
MedCram
00:00
BA 2.86 variant: Risk assessment and impact on immunity
This chapter explores the BA 2.86 variant of COVID-19, discussing its risk assessment, genetic differences, and impact on immunity. It clarifies confusion regarding its infection capability in individuals with previous COVID-19 infection or vaccination. The chapter also examines the mutations present in the variant and the effectiveness of monoclonal antibodies against it.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.